Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?
10.1136/gutjnl-2020-321300
March 10, 2021
GUT Recent advances in basic science
From the origin of NASH to the future of metabolic fatty liver disease
10.1136/gutjnl-2020-323202
February 25, 2021
Niche-specific functional heterogeneity of intestinal resident macrophages
10.1136/gutjnl-2020-323121
December 31, 2020
Targeting G protein-coupled receptors for the treatment of chronic pain in the digestive system
10.1136/gutjnl-2020-321193
December 3, 2020
Gut microbiota-derived metabolites as central regulators in metabolic disorders
10.1136/gutjnl-2020-323071
December 3, 2020
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
10.1136/gutjnl-2020-322526
October 30, 2020
Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links
10.1136/gutjnl-2020-322429
October 16, 2020
Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut health
10.1136/gutjnl-2020-321747
October 13, 2020
Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitis
10.1136/gutjnl-2020-322163
September 24, 2020
Mucus barrier, mucins and gut microbiota: the expected slimy partners?
10.1136/gutjnl-2020-322260
September 11, 2020